BTT-266: A Potent Calcium Channel Blocker for Pain Management

Introducing BTT-266, a groundbreaking compound that holds the key to revolutionizing pain management. This meticulously crafted molecule, identified by the CAS number 2413939-89-4, is a highly selective blocker of voltage-gated calcium channels, a crucial target in the treatment of various pain conditions. Developed through rigorous research and innovation, BTT-266 offers a promising solution for those seeking relief from the debilitating effects of chronic or acute pain.

At the heart of BTT-266's efficacy lies its unique chemical structure. With a molecular formula of C34H28N4O4 and a molecular weight of 556.61 g/mol, this compound boasts a purity of 98%, ensuring consistent and reliable results in both clinical and research settings. Its solid form and distinct color make it easily identifiable, while its solubility characteristics allow for seamless integration into a wide range of formulations and applications.

Unlocking the Power of Calcium Channel Blockade

Voltage-gated calcium channels play a pivotal role in the transmission and perception of pain signals within the body. By selectively blocking these channels, BTT-266 disrupts the flow of calcium ions, effectively inhibiting the propagation of pain impulses. This targeted mechanism of action sets BTT-266 apart, offering a more precise and potentially safer approach to pain management compared to traditional analgesics.

The versatility of BTT-266 extends beyond its primary application in pain relief. Its unique properties also make it a valuable tool in the development of innovative therapeutic strategies, particularly in the fields of neurology and cardiovascular research. By modulating calcium signaling pathways, this compound holds the potential to address a wide range of health conditions, from neuropathic pain to cardiovascular disorders.

Optimizing Pain Management with BTT-266

The exceptional purity and well-defined chemical characteristics of BTT-266 make it an indispensable asset for researchers and clinicians alike. Its powder form, stable at -20°C for up to 3 years, ensures long-term storage and consistent performance, while its solubility in appropriate solvents allows for seamless integration into various experimental and clinical protocols.

Whether you're exploring new pain management strategies, investigating the role of calcium channels in disease pathogenesis, or seeking to develop novel therapeutic agents, BTT-266 stands as a versatile and reliable companion. Its ability to selectively target voltage-gated calcium channels opens up a world of possibilities, empowering researchers to push the boundaries of pain relief and unlock new frontiers in the realm of human health and well-being.

Comprehensive Product Specifications

• CAS Number: 2413939-89-4
• Product Name: BTT-266
• Reference Number: TM-T60010
• Purity: 98%
• Chemical Formula: C34H28N4O4
• Molecular Weight: 556.61 g/mol
• Physical Form: Solid
• Long-term Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Unlock the potential of BTT-266 in your research or clinical endeavors. Explore the wealth of resources available, including scientific literature, technical data, and safety guidelines, to fully harness the power of this remarkable calcium channel blocker. Together, let us embark on a journey to redefine the landscape of pain management and unlock new frontiers in human health.